Trial · NCT03152552
Results by group232
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 232
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in N-terminal Pro B-type Natriuretic Peptide (NT-proBNP) at Week 12 | LIK066 2.5mg | 0.8 | 95% Confidence Interval 0.5 to 1.2 | ratio | |
| Change From Baseline in N-terminal Pro B-type Natriuretic Peptide (NT-proBNP) at Week 12 | LIK066 10mg | 0.6 | 95% Confidence Interval 0.2 to 1.7 | ratio | |
| Change From Baseline in N-terminal Pro B-type Natriuretic Peptide (NT-proBNP) at Week 12 | LIK066 50mg | 0.8 | 95% Confidence Interval 0.7 to 1.1 | ratio | |
| Change From Baseline in N-terminal Pro B-type Natriuretic Peptide (NT-proBNP) at Week 12 | Placebo | 1.1 | 95% Confidence Interval 0.8 to 1.6 | ratio | |
| Change From Baseline in Glycated Hemoglobin (HbA1c) at Weeks 12 and 36 | LIK066 2.5mg | Change from BL at Week 12 | -0.29 | Standard Deviation 0.836 | Percentage (%) |
| Change From Baseline in Glycated Hemoglobin (HbA1c) at Weeks 12 and 36 | LIK066 10mg | Change from BL at Week 12 | -0.01 | Standard Deviation 0.508 | Percentage (%) |
| Change From Baseline in Glycated Hemoglobin (HbA1c) at Weeks 12 and 36 | LIK066 50mg | Change from BL at Week 12 | -0.58 | Standard Deviation 0.335 | Percentage (%) |
| Change From Baseline in Glycated Hemoglobin (HbA1c) at Weeks 12 and 36 | EMPA 25mg | Change from BL at Week 12 | -0.44 | Standard Deviation 1.176 | Percentage (%) |
| Change From Baseline in Glycated Hemoglobin (HbA1c) at Weeks 12 and 36 | Placebo | Change from BL at Week 12 | -0.04 | Standard Deviation 0.913 | Percentage (%) |
| Change From Baseline in Glycated Hemoglobin (HbA1c) at Weeks 12 and 36 | LIK066 2.5mg | Change from BL at Week 36 | 0.13 | Standard Deviation 0.961 | Percentage (%) |
| Change From Baseline in Glycated Hemoglobin (HbA1c) at Weeks 12 and 36 | LIK066 50mg | Change from BL at Week 36 | -0.60 | Standard Deviation NA | Percentage (%) |
| Change From Baseline in Glycated Hemoglobin (HbA1c) at Weeks 12 and 36 | Placebo | Change from BL at Week 36 | -1.83 | Standard Deviation 0.321 | Percentage (%) |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Weeks 12 and 36 | LIK066 2.5mg | Change from BL at Week 12 | -1.021 | Standard Deviation 1.0368 | millimoles per litre (mmol/L) |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Weeks 12 and 36 | LIK066 10mg | Change from BL at Week 12 | -2.041 | Standard Deviation 4.9772 | millimoles per litre (mmol/L) |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Weeks 12 and 36 | LIK066 50mg | Change from BL at Week 12 | -0.426 | Standard Deviation 2.1451 | millimoles per litre (mmol/L) |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Weeks 12 and 36 | EMPA 25mg | Change from BL at Week 12 | -1.303 | Standard Deviation 2.4386 | millimoles per litre (mmol/L) |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Weeks 12 and 36 | Placebo | Change from BL at Week 12 | -1.187 | Standard Deviation 3.9653 | millimoles per litre (mmol/L) |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Weeks 12 and 36 | LIK066 2.5mg | Change from BL at Week 36 | 0.392 | Standard Deviation 1.1119 | millimoles per litre (mmol/L) |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Weeks 12 and 36 | LIK066 50mg | Change from BL at Week 36 | -1.200 | Standard Deviation NA | millimoles per litre (mmol/L) |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Weeks 12 and 36 | Placebo | Change from BL at Week 36 | -4.733 | Standard Deviation 0.3055 | millimoles per litre (mmol/L) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03152552/results